Implanted BCIs are electrodes put in paralyzed people’s brains so they can use imagined movements to send commands from their ...

At least 63 biopharma layoff rounds were conducted in the first quarter of this year, with cell and gene biotechs accounting ...

Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business update and announces full year 2024 ...

PM Narendra Modi, industrialist Ratan Tata, biotech pioneer Raj Bhan, and mathematician Srinivasa Ramanujan. Gates recalls ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

(Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases using ...

Living cells are bustling with molecular machines that constantly process energy, matter, and information. Among these ...

According to the report, titled "India Bioeconomy Report 2025", the bioeconomy sector witnessed a 16-fold expansion in the ...

Even still, the pharma deals announced out of the event brought a clear message for the biotech industry. Technology ...

Rapid Enrollment and Dosing of First Patients in PRECISE-AD Trial Underscores the Unmet Need for Better Treatment Options for Alzheimer’s ...

Bioelectronic devices, neural interfaces, biosensors and AI hardware are now easier to make thanks to a streamlined method for fabricating a key material.

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A ...